People: Rockwell Medical Technologies, Inc. (RMTI.O)

RMTI.O on Consolidated Issue listed on NASDAQ Global Market

7.27USD
9 Feb 2010
Price Change (% chg)

$0.04 (+0.55%)
Prev Close
$7.23
Open
$7.29
Day's High
$7.31
Day's Low
$7.23
Volume
22,314
Avg. Vol
44,018
52-wk High
$9.39
52-wk Low
$2.56

view people for:

Summary

Name Age Since Current Position
Chioini, Robert 44 2000 Chairman of the Board, President, Chief Executive Officer
Klema, Thomas 55 1999 Chief Financial Officer, Vice President - Finance, Treasurer, Secretary
Yocum, Richard 53 2009 Vice President - Drug Development and Medical Affairs
Gupta, Ajay 2009 Chief Scientific Officer
Holt, Kenneth 56 2000 Director
Boyd, Ronald 46 2000 Director
Bagley, Patrick 44 2005 Director
» Insider Trading

Biographies

Name Description
Chioini, Robert Robert L. Chioini Chairman of the Board, President, Chief Executive Officer of Rockwell Medical Technologies, Inc. He is a founder of the Company, has served as Chairman of the Board since March 2000, has served as President and Chief Executive Officer since February 1997 and has been one of Directors since formation in October 1996. From January 1996 to February 1997, Mr. Chioini served as Director of Operations of Rockwell Medical Supplies, L.L.C., a company which manufactured hemodialysis concentrates and distributed such concentrates and other hemodialysis products. From January 1995 to January 1996, Mr. Chioini served as President of Rockwell Medical, Inc., a company which manufactured hemodialysis kits and distributed such kits and other hemodialysis products. From 1993 to 1995, Mr. Chioini served as a Regional Sales Manager at Dial Medical of Florida, Inc., which was acquired by Gambro Healthcare, Inc.
Klema, Thomas Mr. Klema has served as the Vice President of Finance, Chief Financial Officer, Treasurer and Secretary of the Rockwell Medical Technologies,since January 1999.
Yocum, Richard Dr. Richard Yocum, M.D. is Vice President - Drug Development and Medical Affairs of Rockwell Medical Technologies, Inc. He joined the Company as Vice President of Drug Development & Medical Affairs in February 2009. Prior to joining the Company, Dr. Yocum spent 15 years in clinical drug development and project team management within the biopharmaceutical industry. Dr. Yocum served as Vice President, Clinical Development & Medical Affairs at Halozyme Therapeutics, Inc. from 2005 to 2008; as Vice President, Clinical Development & Medical Affairs at Chugai Pharma USA, LLC from 2002 to 2005; as Executive Medical Director of Clinical Research at Ligand Pharmaceuticals Inc. from 1995 to 2002 and as Associate Director of Clinical Research at Gensia, Inc. from 1993 to 1995. Dr. Yocum graduated summa cum laude from Dartmouth College and earned his medical degree from Johns Hopkins University School of Medicine. He later completed his internal medicine residency at the University of California San Diego and had a general medicine practice for 11 years.
Gupta, Ajay Dr. Ajay Gupta, M.D., is Chief Scientific Officer of Rockwell Medical Technologies, Inc. Prior to joining Rockwell, Dr. Gupta spent the last seven years as an Associate Professor of Medicine at UCLA and Charles Drew University Schools of Medicine, Los Angeles, CA where he has had an active nephrology practice. Prior to that, Dr. Gupta served on the faculty at Henry Ford Hospital, Detroit, MI, University of Alabama, Birmingham, State University of New York, Syracuse and Washington University, St. Louis. Dr. Gupta also completed a clinical fellowship in Nephrology from Wayne State University, Detroit, Michigan and a research fellowship in Nephrology from Washington University, St. Louis, Missouri. Dr. Gupta, who is the Founder and Chairman of the Indian Society for Bone and Mineral Research, earned his MBBS degree and completed his residency in Internal Medicine from All India Institute of Medical Sciences (AIIMS), New Delhi. Dr. Gupta is the inventor of dialysate iron therapy using Soluble Ferric Pyrophosphate (SFP) and is also the inventor of intravenous (IV) iron therapy using slow continuous infusion of SFP, including as an adjunct to parenteral nutritional admixtures. He has filed a number of patents in the areas of drugs, medical devices and diagnostic tests.
Holt, Kenneth Kenneth L. Holt is Director of Rockwell Medical Technologies, Inc. He has been a Director since March 2000. He was a founder and co-owner of Charleston Renal Care, LLC, a kidney disease management company specializing in the treatment of end-stage renal disease, until its sale to Davita, Inc. in 2005 and since then has been engaged as a private investor. He was a founder and co-owner of Savannah Dialysis Specialists, LLC, a disease management company specializing in the treatment of end-stage renal disease, and served as the Managing Partner from October 1999 until its sale to Davita, Inc. in 2004. From 1996 to October 1999, Mr. Holt served as Vice President for Gambro Healthcare, Inc., in its Carolinas Region, and held the same position at Vivra Renal Care, Inc., its predecessor company, which was acquired in 1997 by Gambro Healthcare, Inc. From 1986 to 1996, Mr. Holt was also the co-owner and Managing Partner of five dialysis clinics that he founded, which serviced approximately 350 dialysis patients.
Boyd, Ronald Ronald D. Boyd is Director of Rockwell Medical Technologies, Inc. He has been a Director since March 2000. He was a founder and co-owner of Classic Medical, Inc., a dialysis and medical products company, and served as the Executive Vice President of Classic Medical, Inc. since its inception in November 1993 until April 2007 when he sold his interest in that company. Following that sale, Mr. Boyd has been engaged as a private investor. From May 1993 to November 1993, Mr. Boyd served as a consultant for Dial Medical of Florida, Inc., a manufacturer and distributor of dialysis products. From 1990 to 1993, Mr. Boyd served as a Regional Sales Manager for Future Tech, Inc., a dialysis products distributor. Mr. Boyd’s term as a director will expire at the 2010 Annual Meeting of shareholders or upon the election and qualification of his successor.
Bagley, Patrick Patrick J. Bagley is Director of Rockwell Medical Technologies, Inc. Patrick J. Bagley has been a Director since July 2005. Mr. Bagley is Senior Partner of the law firm Bagley and Langan, P.L.L.C. and has been a practicing attorney since 1995.

Basic Compensation

Name Fiscal Year Total
Chioini, Robert 992,722
Klema, Thomas 564,419
Yocum, Richard --
Gupta, Ajay --
Holt, Kenneth --
Boyd, Ronald --
Bagley, Patrick --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Chioini, Robert 2,471,250 3,865,605
Klema, Thomas 1,088,750 1,756,413
Yocum, Richard 0 0
Gupta, Ajay 0 0
Holt, Kenneth 0 0
Boyd, Ronald 0 0
Bagley, Patrick 0 0

Insider Trading

Name Shares Traded Price
CHIOINI ROBERT L 1,822 $7.66
CHIOINI ROBERT L 15,038 $7.71
CHIOINI ROBERT L 395 $7.68
CHIOINI ROBERT L 3,669 $7.66
CHIOINI ROBERT L 22,942 $7.61
KLEMA THOMAS E 35,000 $2.19
HAGELSTEIN DAVID A 26,000 $8.54
HAGELSTEIN DAVID A 16,300 $8.41
HAGELSTEIN DAVID A 12,100 $8.34
HAGELSTEIN DAVID A 1,500 $8.06
HAGELSTEIN DAVID A 9,600 $9.05
HAGELSTEIN DAVID A 2,000 $8.78
HAGELSTEIN DAVID A 12,000 $9.02
HAGELSTEIN DAVID A 1,500 $7.63
HAGELSTEIN DAVID A 1,500 $7.63
HAGELSTEIN DAVID A 4,000 $7.63
HAGELSTEIN DAVID A 5,000 $7.76
HAGELSTEIN DAVID A 10,000 $7.76
BOYD RONALD D 1,941 $6.60
BOYD RONALD D 5,000 $6.62
BOYD RONALD D 2,259 $6.54
BOYD RONALD D 800 $6.63
BOYD RONALD D 10,000 $0.55
BOYD RONALD D 5,104 $6.31
BOYD RONALD D 100 $6.93
» Full list on Insider Trading
view people for: